Dougherty Kristen, Collins Jay, Burgess Jessica, Martyak Michael
Am Surg. 2019 Aug 1;85(8):848-850.
Although nonoperative management or embolization with preservation of splenic tissue is preferable, there is a significant risk of continued bleeding ultimately requiring splenectomy. It has been established that elderly patients on anticoagulation (AC) have an increased risk of splenic injury, but there are little data to show whether AC plays a role in outcomes of splenic injury in the setting of trauma. This is a retrospective cohort study, including 168 adults aged 50 to 79 years who presented as a trauma patient to Sentara Norfolk General Hospital from January 1, 2010, to March 31, 2018. The primary outcome is the management of the splenic injury. Of the 168 patients, 30 were presently taking AC at the time of their injury, and 138 were not taking any AC. These groups were similar in average Injury Severity Score, average grade of splenic injury, and average systolic blood pressure on arrival. However, the groups differed significantly in age and hemoglobin on arrival. We found that patients taking AC at the time of injury underwent splenectomy 23.3 per cent of the time, whereas patients not taking AC underwent splenectomy 11.6 per cent of the time ( = 0.045). Patients taking AC failed nonoperative management 20 per cent of the time, whereas patients not taking AC failed 0.7 per cent of the time ( < 0.05). We found that patients taking AC at the time of their traumatic injury were more likely to undergo splenectomy than patients not taking AC. We also found that patients taking AC were more likely to fail nonoperative management.
尽管采用非手术治疗或保留脾组织的栓塞术更为可取,但持续出血的风险很大,最终可能需要进行脾切除术。已经确定,接受抗凝治疗(AC)的老年患者脾损伤风险增加,但几乎没有数据表明AC在创伤情况下脾损伤的预后中是否起作用。这是一项回顾性队列研究,纳入了2010年1月1日至2018年3月31日期间在Sentara诺福克总医院因创伤就诊的168名年龄在50至79岁之间的成年人。主要结局是脾损伤的处理。在这168名患者中,30名在受伤时正在接受AC治疗,138名未接受任何AC治疗。这些组在平均损伤严重程度评分、平均脾损伤分级和入院时平均收缩压方面相似。然而,两组在年龄和入院时血红蛋白方面存在显著差异。我们发现,受伤时接受AC治疗的患者脾切除率为23.3%,而未接受AC治疗的患者脾切除率为11.6%(P = 0.045)。接受AC治疗的患者非手术治疗失败率为20%,而未接受AC治疗的患者失败率为0.7%(P < 0.05)。我们发现,创伤时接受AC治疗的患者比未接受AC治疗的患者更有可能接受脾切除术。我们还发现,接受AC治疗的患者非手术治疗更有可能失败。